Inflammation and CSC Activation

Chronic inflammation plays a significant role in cancer initiation and progression, often leading to the activation of cancer stem cells (CSCs). This track investigates the links between inflammatory signaling pathways—such as NF-κB, IL-6, and TNF-α—and the activation of CSCs. Researchers explore how inflammation within the tumor microenvironment promotes CSC self-renewal, survival, and metastasis. Targeting the inflammatory signals that support CSCs could lead to novel therapeutic strategies that disrupt this relationship, limiting tumor growth and progression. This research highlights the importance of anti-inflammatory agents in cancer treatment, offering new opportunities to inhibit CSC-driven malignancies by reducing inflammation.

    Related Conference of Inflammation and CSC Activation

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Inflammation and CSC Activation Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in